This gene encodes a protein that has a fibronectin type III domain and a C-terminal transmembrane domain, as well as a leucine-rich repeat domain and immunoglobulin-like domain near the N-terminus. The encoded protein may regulate fibroblast growth factor receptors and affect the modification of these receptors, which are glycosylated differently in the Golgi and endoplasmic reticulum. Mutations in this gene are associated with congenital stationary night blindness, type 1F. [provided by RefSeq, May 2013]
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
LRIT3-20-RE | 20 (40 μL) | 200 μL | Request Pricing | |
LRIT3-20-OR | 20 (40 μL) | 200 μL | Request Pricing | |
LRIT3-20-GO | 20 (40 μL) | 200 μL | Request Pricing | |
LRIT3-20-GR | 20 (40 μL) | 200 μL | Request Pricing | |
LRIT3-20-AQ | 20 (40 μL) | 200 μL | Request Pricing |
This gene encodes a protein that has a fibronectin type III domain and a C-terminal transmembrane domain, as well as a leucine-rich repeat domain and immunoglobulin-like domain near the N-terminus. The encoded protein may regulate fibroblast growth factor receptors and affect the modification of these receptors, which are glycosylated differently in the Golgi and endoplasmic reticulum. Mutations in this gene are associated with congenital stationary night blindness, type 1F. [provided by RefSeq, May 2013]
Gene Symbol : LRIT3
Gene Name : Leucine rich repeat, Ig-like and transmembrane domains 3
Chromosome : CHR 4: 109,848,181-109,872,314
Locus : 4q25
Alt. Genes : LRPPRC
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.